Cardio Cases · imaging-noninvasive
Paradoxical low-flow, low-gradient aortic stenosis in an older woman — case discussion
Practice case: a 78-year-old breathless woman with a small aortic valve area, a low gradient, low stroke volume index and preserved LVEF; naming the pattern under ESC/EACTS 2025 and ACC/AHA 2020, measuring at controlled blood pressure, confirming severity with the CT calcium score, and the ESC/EACTS 2025 Class IIa row.
On this page
Study tools
Target exams
- EECC
- ABIM Cardiovascular Disease Certification
Presentation
Practice case (not a real patient). A 78-year-old woman in a regional Australian town is referred with breathlessness on walking uphill and a systolic murmur. Her TTE report reads: calcified trileaflet aortic valve, AVA 0.75 cm² (indexed 0.48 cm²/m²), Vmax 3.5 m/s, mean gradient 31 mm Hg, stroke volume index 29 mL/m², LVEF 64%, small LV cavity with increased relative wall thickness.[2] Her blood pressure at the scan was 164/86 mm Hg and her heart rate 58/min.
Step 1 — Name the pattern
ESC/EACTS 2025 would call this low-flow, low-gradient AS with preserved LVEF: mean gradient <40 mmHg, AVA ≤1 cm², SVi ≤35 mL/m² and LVEF ≥50%.[1] ACC/AHA 2020 Table 13 (Stages of AS) calls Stage D3 symptomatic severe low-gradient AS with normal LVEF or paradoxical low-flow severe AS.[2] The D3 haemodynamic cell reads AVA ≤1.0 cm² (indexed AVA ≤0.6 cm²/m²) with an aortic Vmax <4 m/s or mean ΔP <40 mm Hg AND stroke volume index <35 mL/m², measured when the patient is normotensive (systolic blood pressure <140 mm Hg).[2] Her systolic pressure was 164 mm Hg, so the D3 measurement condition is not yet met.[2]
Step 2 — Fix the conditions of measurement
ACC/AHA 2020 recommends optimisation of blood pressure control before measurement of AS severity in suspected low-flow, low-gradient severe AS with normal LVEF (Stage D3) (COR 1, LOE B-NR).[3] The legend of ESC/EACTS 2025 Figure 6 (integrative imaging assessment of patients with aortic stenosis) says to check for bradycardia or uncontrolled hypertension, which may lead to prolonged ejection time and reduced flow rate.[1] Her GP adjusts her antihypertensives. Repeat TTE at a systolic pressure of 128 mm Hg gives the same AVA, Vmax 3.6 m/s, mean gradient 33 mm Hg and SVi 30 mL/m².
Step 3 — Is it really severe?
ESC/EACTS 2025 Recommendation Table 4 gives recommendations on indications for intervention in symptomatic and asymptomatic severe aortic stenosis, and the recommended mode of intervention.[1] Its footnote c says explanations such as measurement errors, uncontrolled blood pressure and conditions lowering stroke volume, other than severe AS, for a small AVA but low gradient despite preserved LVEF are frequent and must be carefully excluded.[1] Separately, note a of the Figure 6 legend quoted in Step 2 says: in particular, verify LVOT diameter and multiwindow Doppler interrogation; both are rechecked.[1] ACC/AHA 2020 calls measurement of the aortic valve calcium score by CT reasonable to further define severity in suspected low-flow, low-gradient severe AS with normal or reduced LVEF (Stages D2 and D3) (COR 2a, LOE B-NR).[3] ESC/EACTS 2025 says CCT should be performed to quantify the calcium score in women with discordant echocardiographic parameters.[1] Her score is 1650 Agatston units.
The score exceeds the ESC/EACTS 2025 value of >1200 AU in women, which indicates severe AS with high sensitivity and specificity (∼85%).[1] The score is also above the ESC/EACTS 2025 higher threshold for women (>1600 AU), which is very specific.[1] The score exceeds the ACC/AHA 2020 threshold of 1300 for women.[3] ESC/EACTS 2025 says the pathophysiology of AS seems to differ according to sex, with women having less calcium and more fibrosis, and that paradoxical low-flow, low-gradient constellations are frequent and may contribute to the underdiagnosis of severe AS in women.[1]
Step 4 — What the grade triggers
With symptomatic low-flow (SVi ≤35 mL/m²), low-gradient (<40 mmHg) AS, normal LVEF (≥50%) and severe AS now carefully confirmed, the ESC/EACTS 2025 row applies: intervention should be considered (Class IIa, Level B).[1] In its section on symptomatic severe AS, ESC/EACTS 2025 says outcomes are improved with intervention (either TAVI or SAVR) compared with medical treatment alone in patients with low-flow, low-gradient AS and preserved LVEF.[1] The choice between TAVI and SAVR is covered in the AS treatment topic.
Learning points
- ESC/EACTS 2025 says AS may be further categorised by flow state based on SVi when echocardiographic parameters are discordant; 35 mL/m² is conventionally accepted to discern low from normal flow, although sex-specific thresholds have been proposed.[1]
- ACC/AHA 2020 Stage D3 is measured when the patient is normotensive (systolic blood pressure <140 mm Hg), and in suspected low-flow, low-gradient severe AS with normal LVEF, optimisation of blood pressure control before measurement of AS severity is recommended (COR 1, LOE B-NR).[2][3]
- Calcium thresholds differ by body: ESC/EACTS 2025 >1200 AU in women (>2000 AU in men), which indicates severe AS with high sensitivity and specificity (∼85%); ACC/AHA 2020 1300 in women (2000 in men).[1][3]
- ESC/EACTS 2025 says intervention should be considered in symptomatic low-flow, low-gradient AS with normal LVEF after careful confirmation that AS is severe (Class IIa, Level B).[1]
References3ShowHide
- [1]Praz F, et al. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2025.PMID 40878295
- [2]Otto CM, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021.PMID 33332150
- [3]Otto CM, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2021.PMID 33342586